The second revolution in gene therapy that has cured Javier, a child with a lethal error in the X chromosome
By Oriol Güell,
El País
| 02. 17. 2025
A “small strand of blood in the poop.” This was the first sign, initially viewed as unimportant, that put Jesús Lunar and Cristina López on the trail that something was happening with their son’s health. Javier had been born on June 12, 2020, and before the discovery, which occurred a few days later, everything had been following the chaotic routines that new members of any family impose. Six months later, however, the doctors sat the couple down and gave them the news that was going to change their lives.
“We were told that Javier had Wiskott-Aldrich syndrome, a rare genetic disease that affects the immune system. At first we didn’t know how to react, it was hard for us to accept that it could be fatal. But then something in your head clicks. You tell yourself that you have to keep going and that everything that needs to be done will be done. And so it has been to this day,” says this computer programmer born in 1982.
Javier is almost five years old now and, apart from some minor...
Related Articles
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...
By Diaa Hadid and Shweta Desai, NPR | 01.29.2026
MUMBRA, India — The afternoon sun shines on the woman in a commuter-town café, highlighting her almond-shaped eyes and pale skin, a look often sought after by couples who need an egg to have a baby.
"I have good eggs,"...
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...
By Staff, ScienceDaily | 01.05.2026
Scientists at UNSW Sydney have developed a new form of CRISPR technology that could make gene therapy safer while also resolving a decades-long debate about how genes are switched off. The research shows that small chemical markers attached to DNA
...